News
News
Healthtech
Pharma
Hospitals & Providers
Diagnostics
Medical Devices
Policy & Public Health
Finance
Precision Medicine
Global
Podcast
Insights
VOH Exclusives
VOH Exclusives
Brands in Focus
Idea Leader
Listicles
Editorials
Knowledge Hub
Patient Corner
VOH TV
VOH TV
Expert Speaks
The Big Idea
Daily Broadcast
Bold Voices
Compassionate Voices
Events
Events
Health Awareness
Conferences & Summits
Brand Solutions
Impact Reports
Impact Reports
IVF
Careers
Metastatic Breast Cancer
Pharma
Athira Pharma Licenses Lasofoxifene For Metastatic Breast Cancer, Secures $236 Million Funding
By Team VOH
22 Dec 2025
2 min read
Precision Medicine
Pfizer Reports Positive Phase 3 Results for TUKYSA® in First-Line HER2+ Metastatic Breast Cancer
By Team VOH
15 Oct 2025
2 min read
Voice Of HealthCare
vohnetwork.com
INSTALL APP
